Abstract
A dexamethasone binding protein was detected in cytosol of 11 human synovial tissues from patients with chronic polyarthritis. The apparent dissociation constant (K D) ranged from 3.3 to 17.1 (mean, 7.0 ± 4.3) nmol/liter, and the receptor concentration (R o) from 17 to 65 (mean, 42 + 15) fmol/mg protein. Results of competition assays with an excess of unlabeled aldosterone, estradiol, pregnenolone, and testosterone confirmed that the binding protein had characteristics of a glucocorticoid receptor. With the use of diisopropylfluorophosphate (DFP) for esterase inhibition, and considering the purity of the starting material and the hydrolysis products, we could determine the relative receptor affinities of glucocorticoid-21-esters. In contrast to the high affinity of the glucocorticoid-17-ester examined, esterification in position 21 abolishes binding affinities. Glucocorticoid-21-esters are true prodrugs for which the glucocorticoid action is caused only by the corresponding glucocorticoid alcohol.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
J. L. Hollander, E. M. Brown, R. H. Jessar, and C. Y. Brown. JAMA 147:1629–1633 (1951).
J. L. Hollander. Ann. N.Y. Acad. Sci. 61:511–516 (1955).
F. Hirata. In I. Otterness, R. Capetola, and S. Wong (eds.), Advances in Inflammation Research, Vol. 7, Raven Press, New York, 1984, pp. 70–78.
R. J. Flower, J. N. Wood, and L. Parente. In I. Otterness, R. Capetola, and S. Wong (eds.), Advances in Inflammation Research, Vol. 7, Raven Press, New York, 1984, pp. 61–70.
M. Ponec, J. Kempenaar, B. Shroot, and J. C. Caron. J. Pharm. Sci. 75:973–975 (1986).
P. Rohdewald, H. W. Möllmann, M. K. Müller, and G. Hochhaus. In Boehringer Ingelheim KG (ed.), Bochumer Treff 1984, Verlag Gedon & Reuss, München, 1984, pp. 223–242.
A. Z. Soho, K. M. Trampasch, D. W. Szelo, and M. J. Suto. J. Med. Chem. 25:747–749 (1982).
P. Rohdewald, H. W. Möllmann, and G. Hochhaus. Atemw.-Lungenkrkh. 9:484–489 (1984).
R. C. O'Neill and J. E. Carless. J. Pharm. Pharmacol. 32:10P (1980).
J. M. Wright, J. J. Cowper, P. D. Page Thomas, and C. Knight. Clin. Exp. Rheumatol. 1:137–141 (1983).
J. M. Wright, C. C. Knight, and Z. M. Hunneyball. Clin. Exp. Rheumatol. 4:331–339 (1986).
G. Hochhaus, P. Rohdewald, H. W. Möllmann, and D. Greschuchna. Res. Exp. Med. 182:71–76 (1983).
O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. J. Biol. Chem. 193:265–274 (1951).
D. O. Toft and J. Gorski. Proc. Natl. Acad. Sci. USA 55:1574–1579 (1966).
G. Scatchard. Ann. N.Y. Acad. Sci. 51:660–672 (1949).
H. Derendorf, P. Rohdewald, G. Hochhaus, and H. W. Möllmann. J. Pharm. Biomedic. Anal. 4:197–206 (1986).
C. W. Distelhorst and R. Miesfeld. Blood 69:750–756 (1987).
H. Bojar, W. Westerkamp, and C. Broelsch. Hepato-Gastrerol. 27:176–179 (1980).
M. Snochowski, T. Sartok, E. Dahlberg, E. Erikson, and J. A. Gustafsson. J. Steroid Biochem. 14:765–772 (19 ).
A. Hughes and H. Yardley. Br. J. Dermatol. 106:299–304 (1982).
F. O. Raneletti, M. Carmignani, S. Iacobelli, and P. Tonali. Cancer Res. 38:516–520 (1978).
F. O. Raneletti, S. Iacobelli, M. Carmignani, G. Sica, C. Natoli, and P. Tonali. Cancer Res. 40:2020–2025 (1980).
S. Tsuboi, R. Kawashima, O. Tomioka, M. Nakato, N. Sakamoto, and N. Fujita. Brain Res. 179:181–189 (1979).
C. Bonne and J. B. Raynaud. Steroids 27:497–507 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pörtner, M., Möllmann, H. & Rohdewald, P. Glucocorticoid Receptors in Human Synovial Tissue and Relative Receptor Affinities of Glucocorticoid-21-Esters. Pharm Res 5, 623–627 (1988). https://doi.org/10.1023/A:1015966618864
Issue Date:
DOI: https://doi.org/10.1023/A:1015966618864